Lee P Shulman

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Coronavirus Disease

Clinical Evaluation

Top Venues

Advances in therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

Obstetrics and gynecology international

This page only lists publications with an associated author ORCID identifier.

Publications

Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety (2024)
Vera A Kachko, Lee P Shulman, Irina V Kuznetsova, Yulia B Uspenskaya, Denis I Burchakov
Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen ® and Smart B ® in Women with Climacteric Syndrome in Perimenopause. Advances in therapy (2024)
Vera A Kachko, Lee P Shulman, Irina V Kuznetsova, Yulia B Uspenskaya, Denis I Burchakov
Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen ® and Smart B ® in Women with Climacteric Syndrome in Perimenopause. Advances in therapy 41 (8) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
David N Buckley, Juan Pablo Lewinger, Gerald Gooden, Monique Spillman, Monica Neuman, Xiaoyue Mona Guo, Ben Yi Tew, Heather Miller, Varun U Khetan, Lee P Shulman, Lynda D Roman, Bodour Salhia
OvaPrint™ - a cell-free DNA methylation liquid biopsy for the risk assessment of high-grade serous ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Viktor E Radzinsky, Yulia Uspenskaya, Lee P Shulman, Irina V Kuznetsova
Succinate-Based Dietary Supplement for Menopausal Symptoms: A Pooled Analysis of Two Identical Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Obstetrics and gynecology international 2019 (2019)
Lee P Shulman, Marra Francis, Rowan Bullock, Todd Pappas
Clinical Performance Comparison of Two In-Vitro Diagnostic Multivariate Index Assays (IVDMIAs) for Presurgical Assessment for Ovarian Cancer Risk. Advances in therapy 36 (9) (2019)
Carolyn M Ross, Lee P Shulman
Assessing the Role of Reversible Contraceptives in the Health Care of Women as it Pertains to Cancer Prevention. Advances in therapy 34 (11) (2017)